Edwards Lifesciences Corporation
$86.60
-1.8%(24h)Today
-1.8%
30 Days
1.2%
Price Change (24h)
-$1.61
Today
-1.8%
30 Days
1.2%
Price Change (24h)
-$1.61
The live price of Edwards Lifesciences Corporation is $86.60 per REW/USD, -1.83% in the last 24 hours. It has a market cap of — and $354.36M in trading volume over the same period. Prices are averaged across every exchange we track and update continuously.
Current price
$86.6024h high
$88.4724h low
$85.5424h
-1.83%7d
+1.88%30d change
-2.46%Rank
—
Market Cap
—
24h Volume
$354.36M
Across 1 exchanges
FDV
—
Circulating Supply
—
Total Supply
—
Max Supply
—
No fixed cap
Listed on
1 exchanges
The asset this tracks
Company
Edwards Lifesciences
Ticker
EW
Share price
$89.91
Company market cap
$51.82B
REW vs EW
-3.68%
Shares trade only during market hours while this token trades continuously, so the comparison uses the last available share price. Updated Sep 3, 2026.
What is a tokenized stock?
REW is a crypto token whose price tracks Edwards Lifesciences (EW) shares. It is not the share itself. How it is structured depends on the issuer — some tokens are backed one-for-one by real shares held in custody, others are synthetic and simply follow the price. Check the issuing exchange's terms before trading.
Holding a tokenized stock does not usually grant shareholder rights — no voting, and dividends are handled differently or not at all. You are exposed to the issuer and the exchange as well as to the share price.
Information only, not investment advice. Tokenized equities carry issuer and counterparty risk, and availability is restricted in many jurisdictions.
Edwards Lifesciences Corporation is available on 1 exchanges. Prices shown are live.
| Exchange | Pair | Volume | Trade |
|---|---|---|---|
| Bitget | REWUSDT | — | Buy REW on Bitget |
We may earn a commission when you sign up through these links. This never affects the prices shown.
Trade REW with virtual money. Nothing here is a real order, and no deposit is ever taken.
Trade REW risk-free
Buy and sell Edwards Lifesciences Corporation at live market prices using virtual cash.
Track your portfolio
Watch profit and loss update against real prices, position by position.
Climb the leaderboard
Your returns are ranked against every other player in the league.
Free to play
No deposit, no card, no real funds at risk — just an account.
Edwards Lifesciences Corporation develops and markets medical devices for treating advanced cardiovascular conditions, operating across the United States, Europe, Japan, and other international markets. Its product lineup includes transcatheter heart valve replacement systems for minimally invasive aortic valve procedures, marketed under the Edwards SAPIEN family. Additionally, the company offers transcatheter repair and replacement solutions for mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
The company also provides surgical structural heart products, such as the INSPIRIS line of aortic surgical valves, which incorporate RESILIA tissue and VFit technology. Other offerings include the KONECT RESILIA, a pre-assembled tissue valve conduit intended for complex combined procedures, and the MITRIS RESILIA valve. These products are sold through a combination of a direct sales force and independent distributors.
Founded in 1958, Edwards Lifesciences Corporation is headquartered in Irvine, California.